Navigation Links
2 carotid artery stenting studies show results comparable to AHA guidelines
Date:10/23/2007

mination of such patients, and although the guidelines were established for surgery (before stenting was practiced), there are no comparable surgical results in this group of patients.

In 1998, the American Heart Association published its 30 day outcome guidelines in Circulation for patients treated with carotid artery surgery. These guidelines were based on the observed stroke and death rates in patients with carotid artery disease who had undergone surgery, called carotid endarterectomy, to treat their condition. The guidelines were based on studies of surgery in patients who did not have excessive risks for anesthesia, etc., but left unanswered what the best therapy is for patients for whom surgery was risky. These two studies are the first demonstration of a therapy providing stroke prevention (carotid artery stenting) in these patients and they provide an option to those facing difficult decisions regarding the risks of surgery.

The CAPTURE 2 study included 1,987 patients and utilized Abbott's ACCULINK(tm) Carotid Stent System and ACCUNET(tm) Embolic Protection System. The EXACT study included 2,124 patients and utilized Abbott's Xact(r) Rapid Exchange Carotid Stent System and Emboshield BareWire(tm) Rapid Exchange Embolic Protection System. The key objective of both trials was to determine whether carotid stenting could be performed safely in the real-world clinical setting by physicians with varying levels of experience. The primary endpoints were death, stroke and MI at 30 days. The demographics of patients in both trials were similar.

The 30-day composite endpoints of stroke and death for patients in the CAPTURE 2 and EXACT studies were:

  • 3.1 percent and 3.0 percent combined stroke and death in CAPTURE 2 and EXACT patients without symptoms under age 80
  • 6.0 percent and 7.3 percent combined stroke and death in CAPTURE 2 and EXACT patients with symptoms under age 80

  • '/>"/>

Contact: Alex Lyda
mal2133@columbia.edu
917-755-0354
Columbia University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Columbia study shows widely used artery clearing device does not help patients during heart attack
2. Measuring artery repair cells could become new heart disease test
3. Studies reveal methods viruses use to sidestep immune system
4. New studies suggest airborne SARS transmission is possible
5. Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine
6. Two studies document rise of superbugs in the environment
7. UI researcher studies deafness in fruit flies, humans
8. Biased reporting found in cancer prognostic studies
9. Fruit fly studies open new window on cancer research
10. Why do aneurysms form? New studies suggest leading role for white blood cells
11. Studies clarify risk factors for mother-to-child transmission of hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... (Dec. 14, 2009) -- Researchers at Rice University and ... nanoparticle that can be tracked in real time with ... them with a fluorescent dye and kills them with ... examples from a growing field called "theranostics" that develops ... in a single procedure. , The research is available ...
(Date:12/14/2009)... have founded a new journal Cardiovascular Engineering and ... is a forum for research on all aspects of ... of the new quarterly journal will appear in March ... Annals of Biomedical Engineering and Cellular ... Technology will present a wide spectrum of research, ...
(Date:12/14/2009)... a defining feature of humans. That,s until examples of tool ... an array of other mammals. Now, a report in the ... Press publication, adds an octopus to the growing list of ... behavioral trick that the researchers call stilt walking. In it, ... "bowls," makes its eight arms rigid, and raises the whole ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 1Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 2Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 3Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 4Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 49076 5Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 1Premiere Fibers Unveils New Logo Names for Innovative Brands 49074 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 1Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 2Patient Centered Primary Care Collaborative Stakeholders Come to Washington DC for July Working Meeting 49072 3
... 2008 -- Researchers at the Harvard School of Engineering ... optical tweezer with the potential to make biological and ... chips. The tweezer, consisting of a Fresnel Zone Plate ... trap particles without the need for high performance objective ...
... 1 million people taking cholesterol-lowering statins often experience muscle ... when a diabetic takes medication for intestinal worms, his ... the purported health effects of green tea? , ... for these and other physiological mysteries. The answers, it ...
... Two separate criminal events were,open and shut cases ... recorded on video a robber and a thief ... CSS, stated, "These are the first,times that safe ... of,closed-circuit television (CCTV). We look forward to successful,convictions.", ...
Other Biology News:Engineers demonstrate a new type of optical tweezer 2New chemical tool kit manipulates mitochondria, reveals insights into drug toxicity 2New chemical tool kit manipulates mitochondria, reveals insights into drug toxicity 3Corporate Safe Specialists Smart Safes Capture Evidence in Robbery and Theft 2
(Date:12/14/2009)... Dec. 14 Nektar Therapeutics (Nasdaq: ... been appointed to serve on its board of ... leader with over 35 years of experience in ... brings to Nektar extensive industry perspective at an ... W. Robin, President and CEO of Nektar and ...
(Date:12/11/2009)... -- Dendreon Corporation (Nasdaq: DNDN ) announced ... public offering have exercised in full their option ... stock at the public offering price of $24.75 ... increases the size of the offering to an ... Dendreon expects to receive net proceeds from the ...
(Date:12/11/2009)... ASA (OSE: ALGETA), the,cancer therapeutics company, announces ... the Tulane Cancer Center, New Orleans, has ... study of Alpharadin in men with,castration-resistant (also ... metastasized to the skeleton. , ... Prostate CAncer) study is a,double-blind, randomized, controlled ...
(Date:12/10/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today that ... shares of its common stock at a price to ... granted to the underwriters a 30-day option to purchase ... to cover overallotments, if any. The offering is ... customary closing conditions. ,, J. P. Morgan Securities Inc. ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3
... Wednesday it has entered into an agreement with ... PPO network and stop-loss services for the clients of ... initiative is directed at self-funded employers with 100 to ... ,Aetna will offer a package of stop-loss, PPO provider ...
... Those who venture into the conference room at Neohapsis, ... poster depicting Kelly Hansen as an entrepreneurial superhero. Created ... of the poster is located at Milwaukee's Discovery World ... Comics-inspired Hall of Entrepreneurs because of the tremendous obstacles Hansen ...
... in a UW-Madison lab. Photo courtesy Professor Su-Chun Zhang. ... may affect Wisconsin's leadership in the field of embryonic ... Stem Cell Research and Cures Initiative , or Proposition ... over 10 years for embryonic stem cell researchplacing the ...
Other Biology Technology:Fiserv Health and Aetna help employers control health care costs 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 3Referendum may pull California to the forefront of stem cell research 2Referendum may pull California to the forefront of stem cell research 3Referendum may pull California to the forefront of stem cell research 4Referendum may pull California to the forefront of stem cell research 5
...
...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: